Intellectual Property India Publishes Patent Application for 'Piperidinopyrimidine Derivative, Preparation Method Therefor And Use Thereof In Medicine' Filed by Tuojie Biotech Co. Ltd.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517047515 A) filed by Tuojie Biotech Co. Ltd., Shanghai, on May 16, for 'piperidinopyrimidine derivative, preparation method therefor and use thereof in medicine.'

Inventor(s) include Zhu, Guodong; Hu, Tao; Chen, Meijun; Huo, Shuhua; Li, Jiao; and Li, Yunfei.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a piperidinopyrimidine derivative, a preparation method therefor and the use thereof in medicine. Specifically, the present disclosure relates to a piperidinopyrimidine derivative as represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative, and the use thereof as a CDK7 inhibitor in the treatment of diseases or conditions related to abnormal activity of CDK7. Each group in general formula (I) is as defined in the description."

The patent application was internationally filed on Oct. 25, 2023, under International application No.PCT/CN2023/126415.

Disclaimer: Curated by HT Syndication.